Mild Cognitive Impairment Clinical Trial
Official title:
Memory Group Intervention for Mild Cognitive Impairment: Impact of a Memory Group for Older Adults Reporting Memory Difficulties.
Aims:
To evaluate the efficacy of a brief intensive intervention for persons with mild cognitive
impairment, assisted by family members or friends. To equip persons with mild cognitive
impairment with specific skills to prevent memory failures and improve the capacity of
patients and families to cope with everyday memory difficulties.
Participants:
The sample will consist of 60 families who have a family member reporting memory loss and
who have recently been assessed within the Cognitive Dementia and Memory Service (CDAMS).
Participants will include patients and a family member / close friend. The potential patient
participants must have received a diagnosis of mild cognitive impairment following a
comprehensive clinical assessment. They must also be English speakers, live in the
community, have no evidence of significant visual or auditory impairment, and have no
history of diagnosed alcohol or drug abuse or major psychological disorder. Potential family
/ friend participants are expected to be spouses or adult children.
Brief Description:
Patients and their carers will be assigned to either a 'brief intervention group' or a 'no
intervention group'. Over 5 1 1/2 -hour weekly sessions, the brief intervention group will
be taught a memory skills program which emphasises practical strategies for dealing with
everyday memory problems. Interactive group discussion and 'take home' exercises are also
included. The no intervention group will serve as a control group, and will receive only
their usual care from the the memory clinic. At the completion of the study, the brief
intervention will be offered to those in the no intervention group.
All participants will complete questionnaires about knowledge of memory techniques, common
memory and behaviour problems and emotional health at pre-intervention, post-intervention
and after a 3-month follow-up.
Methods of Data Analysis:
Outcome evaluation will be monitored by neuropsychological assessments of memory
performance, and subjective self-reports. A 2 x 3 multivariate analysis of variance (MANOVA)
will be used to assess differences on the experimental measures between groups (brief
intervention, no intervention) across repeated assessment phases (pre-intervention,
post-intervention, 3-month follow-up).
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator)
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A |